Histone Deacetylase HDAC8 Promotes Insulin Resistance and β-Catenin Activation in NAFLD-Associated Hepatocellular Carcinoma
Yuan Tian(Duke University), Henry Lik‐Yuen Chan(Radiant Research (United States)), Joanna H. Tong(Chinese University of Hong Kong), Mingyan Zhou(Shenzhen University Health Science Center), Tim H.‐M. Huang(UNSW Sydney), Ka‐Fai To(Chinese University of Hong Kong), Alfred S.L. Cheng(Chinese University of Hong Kong), Jiayun Shen(Chinese University of Hong Kong), Grace Lai‐Hung Wong(Chinese University of Hong Kong), Jun Yu(Yueyang Second People's Hospital), Gang Xu(Wuhan University), Vincent Wai‐Sun Wong(Chinese University of Hong Kong), Weiqin Yang(Chinese University of Hong Kong), Hanyong Sun(Shanghai Jiao Tong University), Paul B.S. Lai(Chinese University of Hong Kong), Minnie Y.Y. Go(Therapeutics Clinical Research), Yue S. Cheung(Chinese University of Hong Kong)
Cited by 133
Related Papers
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
|Journal of Clinical Oncology|2014|2.8k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
|The Lancet. Gastroenterology & hepatology|2016|2k